Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Investors & Dealmaking

Hologic Uses COVID Funds to Prep for Post-COVID Opportunities

A handful of major diagnostics companies are flush with unprecedented gains from COVID-19 testing revenues. Hologic is using its COVID windfall to reshape its business in a post-pandemic world even as investors worry that the momentum is unsustainable.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

Systems of Care: Nile AI Tackles the Biggest Problem in Epilepsy

Many epilepsy patients cannot live the lives they want because of the unpredictability of seizures. The founders of Nile AI believe that doesn’t have to be the case. Spun-off from UCB, a leader in the development of epilepsy drugs, Nile AI is developing a systematic solution in a platform that unites all epilepsy stakeholders in the goal of rapidly getting each patient into the therapy that works best for them

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
More From MedTech Strategist:

Teladoc Inks $18.5 Billion Mega-Deal for Livongo

In the largest deal of its kind thus far, telehealth provider Teladoc plans to merge with remote chronic care company Livongo, creating a digital health heavyweight with widespread implications for the US virtual care industry.

Read Article